NCT01468545 Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System Status COMPLETED Phase N/A
NCT01461343 Evaluation of Pulmonary Perfusion Heterogeneity and Compliance in Patients With Pulmonary Hypertension Using Positron Emission Tomography Imaging Status COMPLETED Phase NA
NCT01458236 A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor Status WITHDRAWN Phase PHASE3
NCT01457781 Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE2
NCT01457170 Effects of Apelin on the Lung Circulation in Pulmonary Hypertension Status UNKNOWN Phase NA
NCT01451255 Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging Status COMPLETED Phase N/A
NCT01447628 IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients Status COMPLETED Phase PHASE2
NCT01445873 Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase N/A
NCT01433328 Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain Status TERMINATED Phase PHASE4
NCT01431716 Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT01431326 Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Status COMPLETED Phase N/A
NCT01409122 Safety, Tolerability, and PK Parameters of Sodium Nitrite Inhalation Solution in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01397110 Respiratory and Physical Therapy in Patients With Associated Pulmonary Arterial Hypertension (APAH) With Congenital Heart Defects Status RECRUITING Phase NA
NCT01392495 Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) Status TERMINATED Phase PHASE3
NCT01392469 Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants Status COMPLETED Phase PHASE3
NCT01391104 Responsiveness of Exercise Tests in Pulmonary Arterial Hypertension Status COMPLETED Phase NA
NCT01389206 Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Status COMPLETED Phase N/A